A phase I trial of GRN163L (GRN), a first-in-class telomerase inhibitor, in advanced solid tumors

被引：0
|
作者：
Ratain, M. J.
Benedetti, F. M.
Janisch, L.
Khor, S.
Schilsky, R. L.
Cohen, E. E.
Maitland, M. L.
Elias, L.
LoRusso, P. M.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Geron Corp, Menlo Pk, CA USA
[3] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3581
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmacodynamics (PD) of GRN163L in a Phase I study in refractory, solid tumors
    Ratain, M.
    Smith, J. A.
    Benedetti, F. M.
    Ellas, L.
    LoRusso, P.
    EJC SUPPLEMENTS, 2008, 6 (12): : 138 - 138
  • [2] Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer
    Gellert, GC
    Dikmen, ZG
    Wright, WE
    Gryaznov, S
    Shay, JW
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 96 (01) : 73 - 81
  • [3] GRN163 and GRN163L, telomerase template antagonists, inhibit the growth of human hepatoma in vivo
    Djojosubroto, MW
    Chin, AC
    Go, N
    Wunder, E
    Karpf, DB
    Rudolph, KL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 77 - 77
  • [4] Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer
    Ginelle C. Gellert
    Z. Gunnur Dikmen
    Woodring E. Wright
    Sergei Gryaznov
    Jerry W. Shay
    Breast Cancer Research and Treatment, 2006, 96 : 73 - 81
  • [5] Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
    Shammas, M. A.
    Koley, H.
    Bertheau, R. C.
    Neri, P.
    Fulciniti, M.
    Tassone, P.
    Blotta, S.
    Protopopov, A.
    Mitsiades, C.
    Batchu, R. B.
    Anderson, K. C.
    Chin, A.
    Gryaznov, S.
    Munshi, N. C.
    LEUKEMIA, 2008, 22 (07) : 1410 - 1418
  • [6] Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
    M A Shammas
    H Koley
    R C Bertheau
    P Neri
    M Fulciniti
    P Tassone
    S Blotta
    A Protopopov
    C Mitsiades
    R B Batchu
    K C Anderson
    A Chin
    S Gryaznov
    N C Munshi
    Leukemia, 2008, 22 : 1410 - 1418
  • [7] In vivo inhibition of lung cancer by GRN163L:: A novel human telomerase inhibitor
    Dikmen, ZG
    Gellert, GC
    Jackson, S
    Gryaznov, S
    Tressler, R
    Dogan, P
    Wright, WE
    Shay, JW
    CANCER RESEARCH, 2005, 65 (17) : 7866 - 7873
  • [8] Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma
    Djojosubroto, MW
    Chin, AC
    Go, N
    Schaetzlein, S
    Manns, MP
    Gryaznov, S
    Harley, CB
    Rudolph, KL
    HEPATOLOGY, 2005, 42 (05) : 1127 - 1136
  • [9] GRN163L, a telomerase inhibitor under development for cancer treatment: data guiding clinical trial design
    Tressler, R.
    Kornbrust, D.
    Chin, A.
    Harley, C.
    Behrs, M.
    Elias, L.
    EJC SUPPLEMENTS, 2006, 4 (12): : 188 - 188
  • [10] Results of a Phase I Study of GRN163L, a Direct Inhibitor of Telomerase, in Patients with Relapsed and Refractory Multiple Myeloma (MM).
    Chanan-Khan, Asher Alban
    Munshi, Nikhil C.
    Hussein, Mohamad A.
    Elias, Laurence
    Benedetti, Fabio
    Smith, Jennifer
    Khor, Soo-Peang
    Huff, Carol A.
    BLOOD, 2008, 112 (11) : 1263 - 1263
12345